These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 9792265)

  • 1. Wavelet decomposition analysis of the signal averaged electrocardiogram used for risk stratification of patients with hypertrophic cardiomyopathy.
    Englund A; Hnatkova K; Kulakowski P; Elliot PM; McKenna WJ; Malik M
    Eur Heart J; 1998 Sep; 19(9):1383-90. PubMed ID: 9792265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of spectral turbulence analysis for the identification of patients at high risk for ventricular fibrillation and sudden death in patients with hypertrophic cardiomyopathy.
    Englund A; Hnatkova K; Kulakowski P; Elliot PM; Malik M; McKenna WJ
    Cardiology; 1998 Oct; 90(2):79-82. PubMed ID: 9778542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of time and frequency domain, and spectral temporal mapping analysis of the signal-averaged electrocardiogram in identification of patients with hypertrophic cardiomyopathy at increased risk of sudden death.
    Kulakowski P; Counihan PJ; Camm AJ; McKenna WJ
    Eur Heart J; 1993 Jul; 14(7):941-50. PubMed ID: 8375420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective detection of vulnerability to sustained ventricular tachycardia in patients awaiting cardiac transplantation.
    Lindsay BD; Osborn JL; Schechtman KB; Kenzora JL; Ambos HD; Cain ME
    Am J Cardiol; 1992 Mar; 69(6):619-24. PubMed ID: 1536111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal-averaged electrocardiography in hypertrophic cardiomyopathy.
    Cripps TR; Counihan PJ; Frenneaux MP; Ward DE; Camm AJ; McKenna WJ
    J Am Coll Cardiol; 1990 Apr; 15(5):956-61. PubMed ID: 2312981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of patients with hypertrophic cardiomyopathy at high risk for sudden death.
    Chang AC; McAreavey D; Fananapazir L
    Curr Opin Cardiol; 1995 Jan; 10(1):9-15. PubMed ID: 7787270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy.
    Wang W; Lian Z; Rowin EJ; Maron BJ; Maron MS; Link MS
    Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28314849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Gimeno JR; Tomé-Esteban M; Lofiego C; Hurtado J; Pantazis A; Mist B; Lambiase P; McKenna WJ; Elliott PM
    Eur Heart J; 2009 Nov; 30(21):2599-605. PubMed ID: 19689975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M; Schlaepfer J; Kappenberger L; Fromer M
    Schweiz Med Wochenschr; 1997 Apr; 127(15):623-30. PubMed ID: 9198888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiographic and electrocardiographic identification of those children with hypertrophic cardiomyopathy who should be considered at high-risk of dying suddenly.
    Ostman-Smith I; Wettrell G; Keeton B; Riesenfeld T; Holmgren D; Ergander U
    Cardiol Young; 2005 Dec; 15(6):632-42. PubMed ID: 16297259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal-averaged electrocardiography and ventricular tachycardia as predictors of mortality after acute myocardial infarction in elderly patients.
    Mercando AD; Aronow WS; Epstein S; Fishbach M
    Am J Cardiol; 1995 Sep; 76(7):436-40. PubMed ID: 7653440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
    Maron BJ; Savage DD; Wolfson JK; Epstein SE
    Am J Cardiol; 1981 Aug; 48(2):252-7. PubMed ID: 7196685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QRS Fragmentation and QTc Duration Relate to Malignant Ventricular Tachyarrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy.
    Debonnaire P; Katsanos S; Joyce E; VAN DEN Brink OV; Atsma DE; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    J Cardiovasc Electrophysiol; 2015 May; 26(5):547-55. PubMed ID: 25648421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between predictive characteristics of signal-averaged electrocardiographic variables for postinfarction sudden death and ventricular tachycardia.
    Odemuyiwa O; Malik M; Poloniecki J; Farrell T; Millane T; Kulakowski P; Staunton A; Matthies A; Camm AJ
    Am J Cardiol; 1992 May; 69(14):1186-92. PubMed ID: 1575189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Norrish G; Cantarutti N; Pissaridou E; Ridout DA; Limongelli G; Elliott PM; Kaski JP
    Eur J Prev Cardiol; 2017 Jul; 24(11):1220-1230. PubMed ID: 28482693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.